Guizhou Warmen Pharmaceutical

Guizhou Warmen Pharmaceutical Co., Ltd. is a prominent Chinese pharmaceutical company founded in 1996 and based in Guiyang, Guizhou. The company is listed on the New Third Board (NEEQ: 430369) and specializes in the development and manufacturing of traditional Chinese medicines (TCM), particularly Miao ethnic medicines, as well as chemical drugs and health products. Its flagship product, Relinqing Granules, is a market leader in China for the treatment of urinary tract infections and other urological conditions. Warmen operates under an "一体两翼一支撑" (One Body, Two Wings, One Support) strategy, which integrates its core pharmaceutical business with herbal planting subsidiaries and a dedicated e-commerce platform for health products. The company maintains GMP-certified facilities and is recognized as a "Specialized and Sophisticated" enterprise in Guizhou province.